Skip to content

Prototype implementation test at Pharmalize Holding for social implementation of lunch box for improving Minor Health Complaints

Prototype implementation test at Pharmalize Holding for social implementation of lunch box for improving Minor Health Complaints - Beneficial Effect of the Functional Lunch Boxes on Improving Minor Health Complaints

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047062
Enrollment
30
Registered
2023-03-31
Start date
2022-01-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese healthy adult workers

Interventions

Functional Lunch Boxes for 8 weeks, including 180g of sticky barley-rice, 300g of functional side dish and 2g of functional tea. Placebo Lunch Boxes for 8 weeks, including 180g of rice, 300g of non-fu

Sponsors

Medical Front Corporation
Lead Sponsor
National Agriculture and Food Research Organization
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy workers belong to Pharmarise Holding company group who are worried about metabolic syndrome. 2. Subjects between the ages of 30 and 70 who are health-conscious and have Japanese nationality. 3. Subjects who have minor health complaints at before the test. 4. Subjects who have the privately owned smartphones and can use them. 5. Subjects who agree to participate in this study with a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Subjects who are under physicians advice, treatment, and/or medication for schizophreni a depression, mania, neurological disorders, and/or sleep disorders. 2. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal diseases, and/or affected with infectious diseases requiring reports to the authorities. 3. Subjects with major surgical history relevant to the digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc. 4. Subjects with implantable electronic medical devices. 5. Subjects who are under nutritional advice by a physician. 6. Pre- or post-menopausal women complaining of obvious physical changes. 7. Subjects who cannot continue to consume the test foods due to allergic reactions to drugs or foods (especially wheat and grass), and those who regularly use health foods including drugs and supplements that affect stress and sleep. 8. Subjects who regularly use medicines (sleeping pills, psychotropic drugs, etc.) or health foods/supplements (glycine, gamma-aminobutyric acid, L-serine, L-theanine, L-ornithine, reduced coenzyme Q10, etc.) that affect stress and sleep. 9. Heavy smokers, alcohol addicts or subjects with disordered lifestyle. 10. Subjects who donated either 400 ml whole blood within 16 wks (women), 12 wks (men), 200 ml whole blood within 4 wks, or blood components within 2 wks, prior to the current study. 11. Pregnant or lactating women or women who expect to be pregnant during this study. 12. Subjects who currently participate in other clinical trials or participated within the last 4 wks prior to the current study. 13. Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.

Design outcomes

Primary

MeasureTime frame
Minor Health Complains after 8 weeks of ingestion. (Comprehensive valuation by the brief job stress questionnaire and subjective accomplishment

Secondary

MeasureTime frame
Body composition, sleep quality, meal records and meal satisfaction surveys, thoughts on the test

Countries

Japan

Contacts

Public ContactHajime SHIMAZAKI

Medical Front Corporation President

shimazaki_h@mfc-net.com03-6661-0892

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026